Corrections to the Perinatal Guidelines

Date: March 27, 2017
Source: AIDSinfo

On March 27, 2017, the Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States were updated. The Infant ARV Prophylaxis section was updated so that the recommended doses of nevirapine are consistent with those in the Pediatric ARV Guideline.